HRTS vs. THRN
Compare and contrast key facts about Tema Obesity & Cardiometabolic ETF (HRTS) and Thorne HealthTech, Inc. (THRN).
HRTS is an actively managed fund by Tema. It was launched on Nov 20, 2023.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: HRTS or THRN.
Key characteristics
| HRTS | THRN |
|---|
Correlation
The correlation between HRTS and THRN is 0.00. This indicates that the assets' prices tend to move in opposite directions. Negative correlation can be particularly beneficial for diversification and risk management, as one asset may offset the losses of the other during market fluctuations.
Performance
HRTS vs. THRN - Performance Comparison
The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
HRTS vs. THRN - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Tema Obesity & Cardiometabolic ETF (HRTS) and Thorne HealthTech, Inc. (THRN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Not enough dataDividends
HRTS vs. THRN - Dividend Comparison
Neither HRTS nor THRN has paid dividends to shareholders.
Drawdowns
HRTS vs. THRN - Drawdown Comparison
Volatility
HRTS vs. THRN - Volatility Comparison
Tema Obesity & Cardiometabolic ETF (HRTS) has a higher volatility of 4.61% compared to Thorne HealthTech, Inc. (THRN) at 0.00%. This indicates that HRTS's price experiences larger fluctuations and is considered to be riskier than THRN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.